Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec:196:638-640.
doi: 10.1016/j.thromres.2020.09.033. Epub 2020 Oct 8.

Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence

Behnood Bikdeli  1
Affiliations
Editorial

Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence

Behnood Bikdeli. Thromb Res. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Bikdeli reports that he is a consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of IVC filters.

Figures

Fig. 1
Fig. 1
Considerations for clinical trial design, conduct and reporting for COVID-19 therapeutics. Several concepts will be relevant outside of the pandemic, as well.
See this image and copyright information in PMC

Comment on

References

    1. Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., Lopez de Castilla D., Finberg R.W., Dierberg K., Tapson V., Hsieh L., Patterson T.F., Paredes R., Sweeney D.A., Short W.R., Touloumi G., Lye D.C., Ohmagari N., Oh M.D., Ruiz-Palacios G.M., Benfield T., Fätkenheuer G., Kortepeter M.G., Atmar R.L., Creech C.B., Lundgren J., Babiker A.G., Pett S., Neaton J.D., Burgess T.H., Bonnett T., Green M., Makowski M., Osinusi A., Nayak S., Lane H.C. Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2007764. - DOI - PMC - PubMed
    1. JAC Sterne, Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., Annane D., LCP Azevedo, Berwanger O., Cavalcanti A.B., Dequin P.F., Du B., Emberson J., Fisher D., Giraudeau B., Gordon A.C., Granholm A., Green C., Haynes R., Heming N., JPT Higgins, Horby P., Jüni P., Landray M.J., Le Gouge A., Leclerc M., Lim W.S., Machado F.R., McArthur C., Meziani F., Møller M.H., Perner A., Petersen M.W., Savovic J., Tomazini B., Veiga V.C., Webb S., Marshall J.C. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1–13. doi: 10.1001/jama.2020.17023. - DOI - PMC - PubMed
    1. Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383:120–128. - PMC - PubMed
    1. Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038–3044. - PMC - PubMed
    1. Bikdeli B., Madhavan M.V., Gupta A., Jimenez D., Burton J.R., Der Nigoghossian C., Chuich T., Nouri S.N., Dreyfus I., Driggin E., Sethi S., Sehgal K., Chatterjee S., Ageno W., Madjid M., Guo Y., Tang L.V., Hu Y., Bertoletti L., Giri J., Cushman M., Quéré I., Dimakakos E.P., Gibson C.M., Lippi G., Favaloro E.J., Fareed J., Tafur A.J., Francese D.P., Batra J., Falanga A., Clerkin K.J., Uriel N., Kirtane A., McLintock C., Hunt B.J., Spyropoulos A.C., Barnes G.D., Eikelboom J.W., Weinberg I., Schulman S., Carrier M., Piazza G., Beckman J.A., Leon M.B., Stone G.W., Rosenkranz S., Goldhaber S.Z., Parikh S.A., Monreal M., Krumholz H.M., Konstantinides S.V., Weitz J.I., GYH Lip. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. 2020;120:1004–1024. doi: 10.1055/s-0040-1713152. - DOI - PMC - PubMed